Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

v3.23.3
Net Loss per Common Share (Tables)
9 Months Ended
Sep. 30, 2023
Net Loss per Common Share  
Schedule of Diluted Weighted Average Shares Outstanding

    

Nine Months Ended September 30, 

2023

    

2022

Warrants to purchase Common Stock

 

127,296

 

268,699

Options to purchase Common Stock

 

34,890

 

54,128

Unvested Restricted Stock

 

1,369,105

 

1,229,750

Unvested Restricted Stock Units

 

152

 

3,407

Total

 

1,531,443

 

1,555,985